MaaT Pharma SA (EPA:MAAT)
France flag France · Delayed Price · Currency is EUR
7.30
-0.38 (-4.95%)
At close: Jan 30, 2026

MaaT Pharma Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1181118179132-
Market Cap Growth
2.07%36.57%2.32%-40.01%--
Enterprise Value
117975949123-
Last Close Price
7.307.966.988.0013.35-
PS Ratio
29.9834.3936.3555.35135.75-
PB Ratio
14.1710.703.962.953.31-
P/TBV Ratio
21.6112.914.243.093.38-
EV/Sales Ratio
29.8230.0526.4134.22126.09-
Debt / Equity Ratio
1.741.540.690.420.150.38
Asset Turnover
0.080.080.050.030.03-
Inventory Turnover
13.9312.717.4116.05--
Quick Ratio
2.151.812.654.389.937.75
Current Ratio
2.221.902.784.5710.057.76
Return on Equity (ROE)
-183.64%-187.68%-83.41%-41.14%-32.33%-92.67%
Return on Assets (ROA)
-38.10%-43.64%-28.44%-18.00%-15.08%-20.62%
Return on Capital Employed (ROCE)
-92.70%-118.70%-63.50%-38.20%-19.90%-24.50%
Earnings Yield
-26.48%-26.13%-24.34%-17.32%-6.83%-
FCF Yield
-21.65%-20.61%-24.40%-16.76%-6.19%-
Buyback Yield / Dilution
-22.07%-14.95%-14.89%-307.65%-135.06%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.